ArticleJournal of global health2022

COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes from Delta AY.4.2: Cohort and test-negative study of 5.4 million individuals in Scotland.

Steven Kerr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.